ORLANDO -- Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism ...
Hosted on MSN
Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback